Monoclonal antibody-targeted, temperature-sensitive liposomes: In vivo tumor chemotherapeutics in combination with mild hyperthermia

Journal of Controlled Release

Volumn 196, Issue , 2014, Pages 332-343

  Al Ahmady, Zahraa S ^a,b   Chaloin, Olivier ^c   Kostarelos, Kostas ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Antibody; Doxorubicin; Hyperthermia; Liposomes; Targeted

Indexed keywords

ANTIBODIES; CELL CULTURE; CELLS; CYTOTOXICITY; DISEASES; MONOCLONAL ANTIBODIES; TUMORS;

CHEMOTHERAPEUTIC DRUGS; CYTOTOXIC ACTIVITIES; DOXORUBICIN; HYPERTHERMIA; TARGETED; TEMPERATURE SENSITIVE LIPOSOMES; THERAPEUTIC ACTIVITY; TISSUE DISTRIBUTIONS;

LIPOSOMES;

DOXORUBICIN; IMMUNOGLOBULIN G; LIPOSOME; MONOCLONAL ANTIBODY; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; MUC1 PROTEIN, MOUSE; MUCIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER CELL LINE; CANCER CHEMOTHERAPY; CELL CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG HALF LIFE; DRUG RELEASE; DRUG TUMOR LEVEL; FEMALE; HEATING; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; MOUSE; MULTICELLULAR SPHEROID; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; TEMPERATURE SENSITIVITY; TISSUE DISTRIBUTION; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HYPERTHERMIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; SURVIVAL; TEMPERATURE;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIPOSOMES; MICE; MICE, NUDE; MUCIN-1; NEOPLASMS, EXPERIMENTAL; SURVIVAL ANALYSIS; TEMPERATURE; TISSUE DISTRIBUTION;

EID: 84911890947     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.10.013     Document Type: Article

References (55)

1. M.S. Ewer Cardiac safety of liposomal anthracyclines Semin. Oncol. 31 6 Suppl 13 2004 161 181
2. R. Soloman, and A.A. Gabizon Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin Clin. Lymphoma Myeloma 8 2008 21 32
3. A. Gabizon Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models Cancer Chemother. Pharmacol. 66 1 2010 43 52
4. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763
5. V. Torchilin Antibody-modified liposomes for cancer chemotherapy Expert Opin. Drug Deliv. 5 2008 1003 1025
6. C. Mamot, D.C. Drummond, U. Greiser, K. Hong, D.B. Kirpotin, J.D. Marks, and J.W. Park Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells Cancer Res 63 2003 3154 3161
7. J.W. Park Tumor targeting using anti-her2 immunoliposomes J. Control. Release 74 2001 95 113
8. D.B. Kirpotin Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66 2006 6732 6740
9. T. Lammers Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
10. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 2000 1197 1201
11. C.D. Landon, J.Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed. J. 3 2011 38 64
12. www.celsion.com 2013
13. S.M. Sullivan, and L. Huang Enhanced delivery to target cells by heat-sensitive immunoliposomes Proc. Natl. Acad. Sci. U. S. A. 83 16 1986 6117 6121
14. A. Puri HER2-specific affibody-conjugated thermosensitive liposomes (affisomes) for improved delivery of anticancer agents J. Liposome Res. 18 2008 293 307
15. B. Smith Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes) J. Control. Release 153 2011 187 194
16. M. Kullberg, K. Mann, and J.L. Owens A two-component drug delivery system using Her-2-targeting thermosensitive liposomes J. Drug Target. 17 2009 98 107
17. M. Kullberg, J.L. Owens, and K. Mann Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes J. Drug Target. 18 2010 313 320
18. P. Pradhan Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Control. Release 142 2010 108 121
19. J.M. Limacher, and B. Acres MUC1, a therapeutic target in oncology Bull. Cancer 94 2007 253 257
20. E.H. Moase Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer Biochim. Biophys. Acta 1510 2001 43 55
21. M.H. Gaber Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks Int. J. Radiat. Oncol. Biol. Phys. 36 5 1996 1177 1187
22. M. de Smet, E. Heijman, S. Langereis, N.M. Hijnen, and H. Grüll Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study J. Control. Release 150 2011 102 110
23. W.T. Al-Jamal, Z.S. Al-Ahmady, and K. Kostarelos Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia Biomaterials 33 2012 4608 4617
24. J.N. Moreira, T. Ishida, R. Gaspar, and T.M. Allen Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 19 2002 265 269
25. S. Sofou, and G. Sgouros Antibody-targeted liposomes in cancer therapy and imaging Expert Opin. Drug Deliv. 5 2008 189 204
26. C.-W. Chen Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells Int. J. Nanomedicine 6 2011 2567 2580
27. F.Y. Yang Pharmacokinetic analysis of 111 in-labeled liposomal doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound PLoS One 7 9 2012 e45468
28. G. Kong, R.D. Braun, and M.W. Dewhirst Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature Cancer Res. 61 2001 3027 3032
29. A. Gabizon Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res. 54 1994 987 992
30. F. Pastorino Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy Cancer Res. 66 2006 10073 10082
31. A. Fondell In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an 125I-labelled DNA-intercalator J. Drug Target. 19 2011 846 855
32. A.N. Lukyanov, T.A. Elbayoumi, A.R. Chakilam, and V.P. Torchilin Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody J. Control. Release 100 2004 135 144
33. D.E. Lopes de Menezes, L.M. Pilarski, and T.M. Allen In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma Cancer Res. 58 1998 3320 3330
34. T.A. Elbayoumi, and V.P. Torchilin Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice Mol. Pharm. 6 2009 246 254
35. X.B. Xiong Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo Pharm. Res. 22 6 2005 933 939
36. X.B. Xiong Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo J. Pharm. Sci. 94 2005 1782 1793
37. C. Mamot Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res. 65 2005 11631 11638
38. M. Juweid Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier Cancer Res. 52 1992 5144 5153
39. P. Sapra, and T.M. Allen Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs Cancer Res. 62 2002 7190 7194
40. R. Suzuki Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome Int. J. Pharm. 346 2008 143 150
41. F. Pastorino Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 63 2003 7400 7409
42. P. Sapra, and T.M. Allen Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes Clin. Cancer Res. 10 2004 2530 2537
43. L. Eikenes Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx) in human osteosarcoma xenografts Br. J. Cancer 93 2005 81 88
44. L. Davies Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts Cancer Res. 64 2004 547 553
45. G. Kong, and M.W. Dewhirst Hyperthermia and liposomes Int. J. Hyperthermia 15 1999 345 370
46. D.A. Cope, M.W. Dewhirst, H.S. Friedman, D.D. Bigner, and M.R. Zalutsky Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia Cancer Res. 50 1990 1803 1809
47. J.M. Schuster Hyperthermic modulation of radiolabeled antibody uptake in a human glioma xenograft and normal-tissues Int. J. Hyperthermia 11 1995 59 72
48. M.L. Hauck, M.W. Dewhirst, D.D. Bigner, and M.R. Zalutsky Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model Clin. Cancer Res. 3 1997 63 70
49. G. Kong, R.D. Braun, and M.W. Dewhirst Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size Cancer Res. 60 2000 4440 4445
50. T. Karino, S. Koga, and M. Maeta Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors Jpn. J. Surg. 18 1988 276 283
51. K. Fujiwara, and T. Watanabe Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability Acta Pathol. Jpn. 40 1990 79 84
52. A.H. Negussie Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome J. Control. Release 143 2010 265 273
53. A. Bandekar Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin Biomaterials 33 2012 4345 4352
54. D.L. Iden, and T.M. Allen In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach Biochim. Biophys. Acta 1513 2001 207 216
55. T. Yang Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome J. Control. Release 120 2007 169 177